Chest Email Content Delivery
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Guest Access | Sign In via User Name/Password
This Article
Right arrow Full Text (PDF) Free
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Article Archive
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Chute, J. P.
Right arrow Articles by Williams, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Chute, J. P.
Right arrow Articles by Williams, J.
(Chest. 1996;110:165-171.)
© 1996 American College of Chest Physicians

Retreatment of Patients Surviving Cancer-Free 2 or More Years After Initial Treatment of Small Cell Lung Cancer

John P. Chute MD1; Allen Roberts MD, FCCP1; Michael J. Kelley MD2; Bruce E. Johnson MD2; David Venzon PhD3; and John Williams MD4

1 From the Uniformed Services University of the Health Sciences, Bethesda, Md.
2 From the National Cancer Institute, Navy Medical Oncology Branch, Bethesda, Md.
3 From the Biostatistics and Data Management Section National Cancer Institute, Bethesda, Md.
4 From the Department of Pathology, National Naval Medical Center, Bethesda, Md.

Study objective: To assess the outcome after retreatment of patients with small cell lung cancer (SCLC) who redevelop small cell cancer (SCC) 2 or more years after initial therapy.

Design: Retrospective analysis.

Setting: Single government institution: the National Cancer Institute.

Patients: Twenty patients who redeveloped SCC among 65 patients who survived 2 or more years after starting treatment for their initial cancer.

Measurements: The response rate of patients after retreatment, the survival duration from the time of redevelopment of SCC, and the toxicities of retreatment.

Results: Twenty patients redeveloped SCC: 18 with a relapse and 2 with a second primary cancer. Sixteen received treatment after they redeveloped SCLC while four did not. Eleven patients were retreated with chemotherapy alone, two patients received chemotherapy plus chest radiotherapy, one patient received radiotherapy alone, one patient underwent lobectomy, and one patient was treated with a monoclonal antibody followed by chemotherapy. Nine of 16 patients (56%) treated after they redeveloped SCLC had an objective response (3 complete and 6 partial). The median survival of all 20 patients after they redeveloped SCC was 3.9 months (range, 0 to 46 months). The median survival of the patients who were retreated was 6.5 months (range, 1 to 46 months).

Conclusions: Patients who suffer relapses with SCLC 2 or more years from diagnosis are candidates for retreatment.

Key Words: carcinoma • lung neoplasm • recurrence • small cell • survivors • treatment outcome




This article has been cited by other articles:


Home page
 JCOHome page
K. Kaira, T. Ishizuka, N. Sohara, N. Yanagitani, N. Sunaga, T. Tsuchiya, and M. Mori
Small Cell Carcinoma of the Larynx in a Long-Term Survivor of Small-Cell Lung Cancer
J. Clin. Oncol., June 20, 2006; 24(18): 2961 - 2963.
[Full Text] [PDF]

Home page
 Molecular Cancer TherapeuticsHome page
S. Toyooka, K. O. Toyooka, R. Maruyama, A. K. Virmani, L. Girard, K. Miyajima, K. Harada, Y. Ariyoshi, T. Takahashi, K. Sugio, et al.
DNA Methylation Profiles of Lung Tumors
Mol. Cancer Ther., November 1, 2001; 1(1): 61 - 67.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
D. Strassheim, S. H. Shafer, S. H. Phelps, and C. L. Williams
Small Cell Lung Carcinoma Exhibits Greater Phospholipase C-{beta}1 Expression and Edelfosine Resistance Compared with Non-Small Cell Lung Carcinoma
Cancer Res., May 1, 2000; 60(10): 2730 - 2736.
[Abstract] [Full Text]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1996 by the American College of Chest Physicians.